SMS Pharma updates against USFDA statement on Ranitidine Medical Dialogues Bureau13 April 2020 9:01 AM GMTIndia: Through a recent release with the exchanges, SMS Pharma has provided update against USFDA statement on RanitidineSMS Pharma is one of the m...
USFDA Requests Removal of All Ranitidine Products (Zantac) from the Market Medical Dialogues Bureau6 April 2020 3:45 AM GMTThe U.S. Food and Drug Administration has announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine...
Despite USFDA ban, JB Chemicals & Pharma continues to market ranitidine in India Medical Dialogues Bureau4 April 2020 8:16 AM GMTRantac® is being marketed by the Company in India for over 3 decades and so far no serious adverse event has ever been reported
